José
Palacios Calvo
Profesor/a Titular Universidad
![Foto de José](/img/nophoto.png)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (25)
2021
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
2020
-
Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences
American Journal of Surgical Pathology, Vol. 44, Núm. 5, pp. 649-656
-
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification
American Journal of Surgical Pathology, Vol. 44, Núm. 7, pp. 982-990
-
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)
American Journal of Surgical Pathology, Vol. 44, Núm. 2, pp. 149-161
2017
2016
-
High proliferation predicts pathological complete response to neoadjuvant chemotherapy in early breast cancer
Oncologist, Vol. 21, Núm. 2, pp. 150-155
2012
-
Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease
Molecular and Cellular Endocrinology, Vol. 358, Núm. 2, pp. 244-255
-
The EMT signaling pathways in endometrial carcinoma
Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720
2009
-
Transitional cell tumors of the ovary: A comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of brenner tumors and transitional cell carcinomas
American Journal of Surgical Pathology, Vol. 33, Núm. 4, pp. 556-567
2008
-
Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen
Modern Pathology, Vol. 21, Núm. 8, pp. 925-936
2007
-
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families
Modern Pathology, Vol. 20, Núm. 12, pp. 1298-1306
2006
-
PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations
Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472
2005
-
Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous Morules)
American Journal of Surgical Pathology, Vol. 29, Núm. 10, pp. 1322-1329
-
Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities
Modern Pathology, Vol. 18, Núm. 5, pp. 719-727
-
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
Breast Cancer Research and Treatment, Vol. 90, Núm. 1, pp. 5-14
-
Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3
International Journal of Gynecological Pathology, Vol. 24, Núm. 3, pp. 247-253
-
The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors
Clinical Cancer Research, Vol. 11, Núm. 24, pp. 8577-8584
2004
-
Abnormalities in the NF-κB family and related proteins in endometrial carcinoma
Journal of Pathology, Vol. 204, Núm. 5, pp. 569-577
-
Re: Scholten et al. Nuclear β-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465
Journal of Pathology
2003
-
Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia
Journal of Pathology, Vol. 199, Núm. 4, pp. 471-478